baber/WOPTO huggingface dataset:
Patent PT-1644298-E (PT)
Title: Method of preparing stabilised anhydrite iii from plaster and, hydraulic binder thus obtained
Inventor: COUTURIER JEAN
IPC: C04B11/05
Filed: 2004-06-25
Abstract: The invention relates to a method of preparing stabilised calcium sulphate anhydrite III. The inventive method comprises the following successive steps consisting in: a) heating a powdered starting material to a temperature of between 220 DEG C and 320 < DEG >C, so as to form soluble anhydrite III; and b) subjecting the material thus transformed to a thermal quenching process, so as to lower the temperature thereof by at least 150 < DEG >C in order to obtain a temperature that is at least less than 100 < DEG >C and, preferably, less than 80 < DEG >C, in less than 2 minutes and, preferably, in less than 20 seconds, such as to obtain the aforementioned stabilised anhydrite III. The invention is characterised in that the powdered starting material is ground to produce a particle size of less than 200 ñm and, preferably, of less than 150 ñm and mainly comprises calcium sulphate hemihydrate.
Patent PT-1706132-E (PT)
Title: A composition for cartilage therapeutics and using method thereof
Inventor: LEE EUN-YOUNG
IPC: A61L27/38
Filed: 2004-12-07
Abstract: A cartilage therapeutic composition is developed for clinical transplantation into articulatio genu (knee joints) or ankle joints. It has clinical significance for symptomatic cartilage defects of the femoral condyle (medial, lateral, or trochlear) and bone cartilage defects of the talus (anklebone) in human or animal hosts, The cartilage therapeutic composition comprises a mixture of components of chondrocytes isolated and expanded or differentiated from a host such as a human or animal, and thrombin and a fibrinogen matrix containing fibrinogen. An application of the cartilage therapeutic composition is that a mixture of thrombin, chondrocyte components and a fibrinogen matrix is injected into a cartilage defect region followed by solidification therein. It provides rapid healing and effective regeneration of cartilage without surgical operation. It has the merits of safety and simplicity by allowing the use of an arthroscope for transplantation.
Patent PT-1792417-E (PT)
Title: Apparatus, system, and method for managing transmission power in a wireless communication system
Inventor: ODIGIE ERUMUSELE OLUMUYIWA
IPC: H04W52/22
Filed: 2005-09-08
Abstract: An apparatus, system, and method efficiently manage transmission power in a user equipment (UE) device by maintaining and applying an authorized power level to determine a transmission power level after a power limited transmission and before a new power control command has been received. The UE device maintains the authorized power level by monitoring and adjusting the authorized power level based on received power control commands. After a power limited transmission where the maximum power level is less than the authorized power level, the UE device determines the transmission power level for the next transmission based on the authorized power level. Accordingly, after the power limiting situation has ceased, the UE device transmits at the optimum power level eliminating the inefficiencies of transmitting at a lower than authorized power before the next power control command is received.
Patent PT-1838293-E (PT)
Title: Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers
Inventor: KUEHN TORSTEN
IPC: A61K9/48
Filed: 2006-01-06
Abstract: The present invention relates to capsules for housing pharmaceutical preparations for powder inhalers with increased medicinal product safety and capsules for pharmaceutical preparations for powder inhalers with improved adaption to use in powder inhalers. The capsules consist of non-water-soluble, hydrophobic plastics, which themselves do not substantially influence the pharmaceutical quality of the contents, but improve the usability of the filled capsules in respect of their operation, the period of use and/or the geographical location of their use and are advantageous in various steps from manufacture to use.
Patent PT-1900110-E (PT)
Title: Bus modem for building and industrial electrical systems
Inventor: GUSI PIERO CAMILLO
IPC: H04B3/54
Filed: 2006-06-06
Abstract: The present invention relates to a method of modulating development of a cell. The method includes the step of introducing into the cell a nucleic acid with the capacity to modulate development of the cell, the nucleic acid including a target site for binding of a microRNA, wherein the activity and/or concentration of the microRNA in the cell results in a level of activity and/or concentration of the nucleic acid in the cell sufficient to modulate development of the cell.
Patent PT-2015616-E (PT)
Title: Load recognition method for a variable speed drive and device for implementing this method
Inventor: DEMUTH JUERGEN
IPC: H02M5/293
Filed: 2007-07-13
Abstract: The method involves effectively comparing a voltage (Uv) at terminals of a dimmer with a threshold value (Us) adopted dynamically, where the height of the terminals of the dimmer is dependent to a time (t), at which a outage flank (F) is produced. A measuring duration (td) of the voltage point is established at a fixed value, after the outage flank is at the terminal of the dimmer.
Patent PT-2251491-E (PT)
Title: Milling device and method for removing soil material
Inventor: ARZBERGER MAXIMILIAN
IPC: E02D17/13
Filed: 2009-05-15
Abstract: The device (10) has a support- and guide frame (20) at which milling units (30, 40) with milling wheels (31, 41) are arranged in parallel for producing milling cutouts. The milling units are movably supported parallel to each other. Rotation axis of the milling wheel runs transverse to a longitudinal axis of the frame. One of the milling units is movably guided along a drilling direction at the frame independently of another milling unit. A hydraulic lifting device (50) is arranged for moving the milling units, and connected with the support- and guide frame and the milling units. An independent claim is also included for a method for removing soil material.
Patent PT-2323972-E (PT)
Title: C7-fluoro substituted tetracycline compounds
Inventor: PLAMONDON LOUIS
IPC: C07C237/26
Filed: 2009-08-07
Abstract: The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.
Patent PT-2345549-E (PT)
Title: Arm blank and method of manufacturing same
Inventor: YOSHIDA MICHITAKA
IPC: B21D7/08
Filed: 2009-10-19
Abstract: An arm material for an upper arm or a lower arm is provided which constitutes a double wishbone suspension or the like of an automobile and which has a flat, hollow, closed cross-sectional shape and enables further decreases in size, decreases in weight, and increases in strength.  An arm material for an automobile suspension has a body made from a parts material made by metal. The parts material made by metal has a flat, hollow, closed cross-sectional shape having a pair of opposing long sides and is formed from a single member in its lengthwise direction. The body has at least a first bent portion which is bent in a plane roughly parallel to the pair of long sides.
Patent PT-2364309-E (PT)
Title: New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
IPC: C07K5/06
Filed: 2009-12-10
Abstract: The invention provides 4-amino-4-oxobutanoyl peptides of Formula I and the pharmaceutically salts and hydrates thereof. The variables R, R1, R6-R8, R16, R18, R19, M, n, T, Y, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. The 4-amino-4-oxobutanoyl peptides disclosed herein are potent and/ or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptides and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a 4-amino-4-oxobutanoyl peptides as the only active agent or may contain a combination of a 4-amino-4-oxobutanoyl peptides and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections.
Patent PT-968228-E (PT)
Title: Calcium phosphopeptide complexes
Inventor: REYNOLDS ERIC C
IPC: A61P19/08
Filed: 1998-03-13
Abstract: The present invention relates to novel complexes in which amorphous calcium fluoride phosphates are stabilised by phosphopeptides. The complexes have anti-cariogenic effects and may also be used as dietary supplements to increase calcium bioavailability and to heal or prevent diseases associated with calcium deficiencies.
Patent PT-2298391-E (PT)
Title: Portable electronic injection device for injecting liquid medication
Inventor: PONGPAIROCHANA VINCENT
IPC: A61M5/32
Filed: 2005-02-17
Abstract: There is described a medication injection device comprising a housing, a holder (82) for receiving and holding in said housing a medication container an end of which is connectable to a needle, control means and means, controlled by said control means, for pushing liquid medication contained in said medication container out of said medication container through said needle, characterized by comprising sensor means (114-117; 103a, 121, 122), connected to said control means, for detecting proper connection of said needle to said medication container.
Patent PT-2208423-E (PT)
Title: A shelf-stable cooking aid
Inventor: LIEN WEN SZE
IPC: A23L27/10
Filed: 2005-08-26
Abstract: The invention concerns a shelf-stable concentrate cooking aid comprising 
- a reduced amount of natural MSG,IMP and GMP 
- between 10 and 20 % in weight of natural food derived acids and sugars and 
- between 20 and 45 % of naturally derived macromolecules.
Patent PT-2502904-E (PT)
Title: Process for the production of polyisocyanates
Inventor: CARR ROBERT HENRY
IPC: C07C263/10
Filed: 2004-07-28
Abstract: A process for the production of a polyisocyanate comprising (a) phosgenating a polyamine to form a polyisocyanate by reacting (1) a polyamine on which the polyisocyanate is based in solution in an inert solvent with (2) phosgene optionally in solution in an inert solvent, (b) separating the solvent from the polyisocyanate, (c) treating the separated solvent to be reused in polyamine solution (1) with an isocyanate trimerisation catalyst.
Patent PT-659748-E (PT)
Inventor: LANG HANS-JOCHEN
IPC: C07C233/65
Filed: 1994-12-19
Abstract: There are described acylguanidines I <IMAGE> where X is carbonyl or sulphonyl; R(1) is H, (cyclo)alkyl, phenyl; R(2) is H, alkyl, and their pharmaceutically tolerable salts. They are obtained by reaction of a compound II <IMAGE>  with guanidine. The compounds have no undesired salidiuretic properties, but have very good antiarrhythmic properties. As a result of inhibition of the cellular Na<+>/H<+> exchange mechanism, they can be used for the treatment of all acute or chronic injuries induced by ischaemia.
Patent PT-788513-E (PT)
Inventor: BONNEFOY JEAN-YVES MARCEL PAUL
IPC: A61P17/00
Filed: 1995-10-20
Abstract: Binding agents to CD23 can be useful in the treatment of inflammatory, autoimmune or allergic diseases.
Patent PT-727423-E (PT)
Inventor: SUH BYOUNG WOO
IPC: C07D521/00
Filed: 1994-03-04
Abstract: The present invention relates to a process for preparing the sulfonylchloride compound of formula (V) and the compound of formula (VIII), both of which are useful as an intermediate compound for preparing the sulfonylurea derivative of formula (I) and to a novel intermediate compound of formula (VIII): wherein R<sup>1</sup> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl or phenyl, R<sup>2</sup> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl, allyl or propargyl an R<sup>3</sup> represents hydrogen, methyl, ethyl or phenyl.
Patent PT-859634-E (PT)
Inventor: GELOTTE KARL M
IPC: A61K47/02
Filed: 1996-10-23
Abstract: Composition for i.v. administration is new comprises: (a) a compound of formula (I) or its salt; (b) a citrate buffer; and (c) a tonicity-adjusting agent to make the formulation isotonic. In (I), R4 = aryl, 1-10C alkyl or 1-10C arylalkyl; R5 = CO-R8; R8 = OH or 1-10C alkyloxy; m = 2-6; and p = 0 or 1.
Patent PT-959912-E (PT)
Inventor: FRANCHI PIERRE
IPC: A61M60/538
Filed: 1997-02-19
Abstract: PCT No. PCT/FR97/00303 Sec. 371 Date Dec. 11, 1998 Sec. 102(e) Date Dec. 11, 1998 PCT Filed Feb. 19, 1997 PCT Pub. No. WO97/30740 PCT Pub. Date Aug. 28, 1997A pump comprises variable volume means inserted in an artery, in particular, the descending aorta, enabling the volume through which the blood flows in this location to be modified cyclically and in a controlled manner. The device comprises a deformable enclosure in fluid communication with the variable volume. The variable volume and a spring coil urge the deformable enclosure against an increase of volume resulting from a pressure increase in the variable volume, and in the corresponding enclosure, in a way which produces additional elastance for the artery during the heart cycle. In addition, an electric motor can control the deformable enclosure to increase or decrease its volume, and can exert its force in addition to or in subtraction from the force of the spring coil during the systolic and diastolic phases of the heart cycle. This produces an additional pumping effect on arterial blood and correspondingly relieves the effort required of the heart.
Patent PT-967896-E (PT)
Inventor: MARTIN MARIO
IPC: F26B17/04
Filed: 1998-02-05
Abstract: The machine (1) includes a tunnel structure (2) which defines a chamber (8) with inclined, downwardly converging longitudinal side walls (9) and in which a substantially horizontal conveyor (10) for conveying a layered flow of shredded tobacco (T) from the input end (6) to the output end (7) of the chamber (8) extends adjacent the lower edges (9b) of the converging side walls (9). A ventilation system (16-25) is provided in this latter, having a delivery manifold (16) which extends above the conveyor (10), an array of vertical tubes (17) which extend from the delivery manifold (16) to a predetermined distance from the conveyor (10) between the lower edges (9a) of the converging side walls (9), a return manifold (18) communicating with lateral regions of the chamber (8) situated to the sides of the array of tubes (17) and above the converging side walls (9), and air conditioning and recycling apparatus (20-25) interposed between the outlet (23) of the return manifold (18) and the delivery manifold (16) for inducing flow of conditioned air through the tubes (17) towards the conveyor (10) in such a way that the air leaving the tubes (17) creates a bed of air above the conveyor (10) for fluidizing the layered flow of tobacco (T).
Patent PT-931028-E (PT)
Inventor: VILATO PABLO
IPC: C03C10/00
Filed: 1998-07-29
Abstract: A glass-ceramic plate based on silicon, aluminum and lithium oxides is intended, in particular, to cover heating elements. The plate has a diffuse transmission factor of at least 50%. A process for manufacturing the plate is provided.
Patent PT-1035998-E (PT)
Inventor: NIELSEN JENS M
IPC: B63B11/00
Filed: 1998-12-02
Abstract: The invention relates to a transport ship (20) having a hull comprising a sheathing (22), a weather deck (23, 23') and a hold (28, 28', 30), and having a front part (35), a rear part (25) and a central part (29). The ship is unique in that the front part (35) of the ship comprises a hold section (28') defined by the hull and the weather deck (23'), and access hatches provided in the weather deck (23') to give access to said hold section (28'), that the rear part (25) of the ship comprises a hold section (28) defined by the hull and the weather deck (23), and access hatches provided in the weather deck (23) to give access to said hold section (28), that the central part (29) of the ship comprises a refrigerated hold section (30) defined by an upper thermally insulated refrigerated hold deck (130), a thermally insulated bottom and by thermally insulated walls (132, 133...) extending in the transverse direction and longitudinal direction of the ship, and in that the weather deck (23, 23') is adapted to support a cargo.
Patent PT-1056725-E (PT)
Inventor: JACQUES DUMAS
IPC: C07D231/40
Filed: 1998-12-22
Abstract: Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
Patent PT-1033732-E (PT)
Inventor: HOFSASS MARCEL
IPC: H01H1/50
Filed: 1999-12-09
Abstract: The switch has a fixed contact pad (26) that is engaged by a movable contact (25) on the tip of a bimetallic element (23). Bimetallic element is coupled to a leaf spring (17). Contact between pad (26) and contact (25) is opened if too high ambient temperature or due to current flow. At the end of its operational life, arcing which occurs as contact opens welds movable contact in the open position.
Patent PT-955042-E (PT)
Inventor: GRASSET ETIENNE
IPC: A61K31/57
Filed: 1999-04-26
Abstract: A composition comprises a progesterone suspension in a lipophilic medium containing 17 beta -estradiol, at a progesterone/17 beta -estradiol ratio of 25-600 (w/w). Independent claims are also included for: (1) the preparation of the composition; and (2) a medicament comprising the composition.
Patent PT-1078001-E (PT)
Title: Il-6 antagonist peptides
Inventor: SERLUPI-CRESCENZI OTTAVIANO
IPC: A61K38/17
Filed: 1999-05-18
Abstract: The present invention relates to IL-6 antagonist peptides, isolatable from a peptide library through the two-hybrids system by their ability to bind to the intracellular domain of gp130 and containing at least 5 amino acids. In particular, such peptides comprise an amino acid sequence, which is selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO:5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, as well as salts, functional derivatives, precursors and analogs thereof. Another object of the present invention is to provide the peptide in substantially purified form, in order to be suitable for use in pharmaceutical compositions as active ingredient in pathologies that require IL-6 activity inhibition.
Patent IE-38851-L (IE)
Title: Removing vitamin b-2 from whey; production of lactose
IPC: B01D15/00
Filed: 1974-02-13
Abstract: A process for removing the vitamin B2 contained in whey by passing whey having a total solid content of from 6.2- 25% through a column packed with granulated activated carbon derived from petroleum or coal in which more than 55% of the total pores have a diameter of from 40 to 200 A and the pore volume is more than 1.1 cc/g. The granulated activated carbon, saturated with vitamin B2, can be regenerated by passing an aqueous solution of sodium hydroxide and water alternately therethrough for repeated use.
[US3907777A]
Patent IE-38889-L (IE)
Title: Preparation of ampicillin
IPC: C07D499/10
Filed: 1974-02-14
Abstract: Ampicillin is prepared by reacting an inorganic or organic base with a new penicillin G derivative of the formula: OHS ¦ ANGLE CH3 C6H5-CH2-C---N----CH-CHC ANGLE ¦¦¦¦¦CH3 R2O-CS-NC=OO=C--N---CH-COOR1 ANGLE CH ¦ C6H5 (wherein R1 represents a group protecting the carboxy radical and R2 represents a strong electron-attracting group, e.g. a halogenoethyl group) to open the imidazolidine ring and give an intermediate product of the formula: S ANGLE CH3 R2O-CS-NH-CH-CONH----CH-CHC ANGLE ¦¦¦¦CH3 C6H5O=C--N---CH-COOR1 and removing by methods known per se the groups -R1 and R2O-CS- which protect the carboxy radical and amine functions respectively.
[US3926956A]
Patent IE-36944-L (IE)
Title: 17ó-ethynyl-estriols.
IPC: C07J1/00
Filed: 1972-03-08
Abstract: 1336703 17α-Ethynylestriols ELI LILLY & CO 23 March 1972 [24 March 1971 (2) 15 April 1971 23 April 1971] 13523/72 Heading C2U The invention comprises (a) the 3-cyclopentyl ether of 17α-ethynylestriol (I); and (b) a process for separating a compound of formula (wherein R<SP>11</SP> is H, C 1-3 alkyl or C 5-6 cycloalkyl) from a mixture thereof with its 17α-hydroxy- 17#-ethynyl isomer, by treating the mixture with acidic acetone to convert the latter component to its 16,17-acetonide which is then removed, e.g. by chromatography or crystallization. The starting mixture may be obtained by ethynylation of a 16α-alkanoyloxy-estrone or a 3-alkyl ether, 3-cycloalkyl ether or 3-alkanoate thereof. When R<SP>11</SP> is H in the separated compound II, it may be etherified in the 3-position by reaction with an alkali metal alkoxide or thallous ethoxide and reaction of the resulting salt with a C 5-6 cycloalkyl halide. Compound I is said to be estrogenic, and may be made up with carriers into pharmaceutical compositions for oral and parenteral administration. Reference has been directed by the Comptroller to Specification 1,110,759.
[GB1336703A]
Patent IE-830324-L (IE)
Title: Renally active tetrapeptides
IPC: A61P9/12
Filed: 1983-02-16
Abstract: N-Acyltetrapeptides are described which are active in improving renal function. An exemplary species is N-4-(4-hydroxyphenyl)-butyryl-L-prolyl-D,L- alpha -methyl-phenylalanyl-glycyl-L-prolin e.
Patent IE-37384-L (IE)
Title: Pseudo-synovial fluids
IPC: A61K9/08
Filed: 1973-03-08
Abstract: 1391577 Substitute synovial fluid C A HOMSY 8 March 1973 [16 March 1972] 11352/73 Heading A5B [Also in Division C3] A pseudo-synovial fluid comprises an aqueous solution of from 0.8 to 4.0% by weight of sodium carboxy methyl cellulose and the inorganic salts present in blood plasma in approximately the concentration in which they are present in the blood plasma. Such salts include sodium and potassium chlorides, sodium hydrogen carbonate and K 2 H 3 PO 4 . Preferably the sodium carboxymethyl cellulose has a Brookfield viscosity of at least 500 c.p.s. at 25 C. More preferably, it has a molecular weight of about 350,000 and a degree of substitution of 0.8. A microbial agent, preferably methyl-p-hydroxy benzoate, may be added. These materials do not cause inflammation in the body.
[GB1391577A]
Patent IE-850402-L (IE)
Title: Transferrin-vinca alkaloid cytotoxic composition
IPC: A61K47/48
Filed: 1985-02-19
Abstract: There is provided by this invention cell-targeting cytotoxic compositions comprising transferrin covalently coupled to vinca alkaloid.
[US4522750A]
Patent IE-800481-L (IE)
Title: Piperazine
IPC: C07D295/08
Filed: 1980-03-10
Abstract: Derivatives of 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoic acid are prepared which are useful for their blocking action on alpha and beta -adrenergic receptors. In addition, these compounds are useful as spasmolytic and antihypertensive agents.
[US4255575A]